The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-1.4% to $106.00
Predicted High$108.20at 1 month
Predicted Low$104.50at 5 months
Max Drawdown (predicted)-2.8%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 19, 2026 12:21 pm
Neutral
CCEP trends range-bound to
$106.00
(-1.4% from $107.52)
by Feb 2027.
flat-then-break
ThesisCCEP trades slightly above composite fair value but below DCF, with strong quality and consistent earnings beats supporting a gentle drift. Low beta and no near-term catalyst keep the path range-bound, with mild mean reversion toward the mid-100s over the window.
Invalidated ifBreak below $100 support or above $115 on volume; unexpected earnings guidance cut
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $107.52 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 19, 2026
—
$107.52at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Sep 2, 2026
$102.46–$112.58typical range · internal point $107.80
—
±4.7%
7/10
Low-vol drift, risk-on tape offers marginal lift
1 month
Sep 19, 2026
$100.19–$114.85typical range · internal point $108.20
—
±6.8%
6/10
Steady bottler compounder narrative persists
2 months
Oct 19, 2026
$106.50
—
-0.9%
5/10
Mild pullback toward composite fair value
3 months
Nov 19, 2026
$105.00
—
-2.3%
5/10
Value gravity nudges price toward $95 anchor
4 months
Dec 19, 2026
$106.20
—
-1.2%
4/10
Year-end defensive rotation supports low-beta name
5 months
Jan 19, 2027
$104.50
—
-2.8%
4/10
Fair value drag continues absent catalyst
6 months
Feb 19, 2027
$106.00
—
-1.4%
3/10
Settles between fair value and DCF midpoint
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$109.15
(+1.5%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.